This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Israel, Japan, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.
The drug PROPECIA contains one active pharmaceutical ingredient (API):
1
|
UNII
57GNO57U7G - FINASTERIDE
|
|
Finasteride is a competitive inhibitor of human 5α-reductase, an intracellular enzyme which metabolises testosterone into the more potent androgen, dihydrotestosterone (DHT). In benign prostatic hyperplasia (BPH), enlargement of the prostate gland is dependent upon the conversion of testosterone to DHT within the prostate. Finasteride is highly effective in reducing circulating and intraprostatic DHT. Finasteride has no affinity for the androgen receptor. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D11AX10 | Finasteride | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 525501702110315 |
| CA | Health Products and Food Branch | 02238213 |
| EE | Ravimiamet | 1036628 |
| ES | Centro de información online de medicamentos de la AEMPS | 62441 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 484238 |
| FR | Base de données publique des médicaments | 60580369 |
| GB | Medicines & Healthcare Products Regulatory Agency | 109201, 180661, 46599 |
| HK | Department of Health Drug Office | 44266, 63379 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 3726, 6176 |
| JP | 医薬品医療機器総合機構 | 249900XF1021, 249900XF2028 |
| MT | Medicines Authority | MA031/02001, PI908/25301A |
| NL | Z-Index G-Standaard, PRK | 66737 |
| NZ | Medicines and Medical Devices Safety Authority | 7926 |
| PL | Rejestru Produktów Leczniczych | 100091382 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W68215001 |
| SG | Health Sciences Authority | 09921P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8683280337343 |
| US | FDA, National Drug Code | 0006-0071 |
| ZA | Health Products Regulatory Authority | 32/21.12/0303 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.